About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-TS2
A12265G
A12265G-F1
C12224T
C12224T-F1
C12246A
C12258A
C12258A-F2
C12258A-F1
C12262A
C12264T
C12264T-F2
C12264T-F1
G12207A
G12207A-F2
G12236A
G12236A-F1
T12261C
T12261C-F1
Edit by Mitofam Team
-
+
首页
C12262A
# **General Information** | **Position** | **12262** | **Variant** | **m.12262C\>A** | **Locus** | **MT\-TS2** | **RNA** | **tRNA Ser (AGY)** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \- | **Heteroplasmy** | \+ | **mitoTIP** | 84\.50% | **Pathogenicity** | Reported | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.12262C\>A** variant in MT\-TS2 has been reported in 1 pedigree. To date, 1 carrier has been reported. Reported mutation loads ranged from 0% to 63%, with a median of 0% overall; affected carriers showed mutation loads from 0% to 63%, with a median of 0%. In one affected carrier, the mutation was undetectable in blood (0%), urine (0%), bone marrow (0%), and hair (0%) but exceeded 20% in muscle (63%). The main clinical manifestations among affected carriers included progressive mitochondrial myopathy. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 12262 | m.12262C\>A | C12262A\-F1 | Italy | Progressive mitochondrial myopathy | 0 | 0 | 2011 | [21257182](https://pubmed.ncbi.nlm.nih.gov/21257182/) | | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 12262 | m.12262C\>A | C12262A\-F1 | C12262A\-F1\-II2 | De novo | F | Y | Y | A | 53 | 0 | 63% | 0 | 0% (BM), 0% (H) | Progressive mitochondrial myopathy | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月22日 17:35
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)